Aaron Ondrey - 03 Jul 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Chief Financial Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey
Issuer symbol
RCKT
Transactions as of
03 Jul 2025
Net transactions value
-$4,257
Form type
4
Filing time
08 Jul 2025, 16:05:11 UTC
Previous filing
08 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ondrey Aaron Chief Financial Officer C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY /s/ Martin Wilson, as attorney-in-fact for Aaron Ondrey 08 Jul 2025 0001991078

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale $4,257 -1,477 -1.1% $2.88 128,173 03 Jul 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
F2 The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.